Abstract
Tenoxicam is an NSAID of the oxicam group. Its distribution in articular tissues was investigated in 12 patients who required total arthroplasty of the hip. They were given tenoxicam 20 mg once daily for 8 to 30 days before surgery. Blood, synovium and cartilage samples were taken concurrently during surgery, about 14 hours after the last tenoxicam dose. The tissues were ground using a freeze grinder. Tenoxicam was assayed by HPLC. Tenoxicam concentrations averaged 6.21±3.81 μg/ml in plasma, 7.56±4.67 μg/g in synovium and 2.05±1.43 μg/g in cartilage. The individual synovium/cartilage ratios ranged from 1.9 to 9.7. Finally tenoxicam exhibited more affinity for its target organ (synovial tissue) than for joint cartilage.
Similar content being viewed by others
References
P. H. Hinderling, D. Hartmann, C. Crevoisier, U. Moser and P. Heizmann,Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio. Ther. Drug Monit.10, 250–260 (1988).
D. E. Furst,Synovial fluid kinetics of non-steroidal anti-inflammatory drugs. Agents Actions17, 65–78 (1985).
E. V. Hess and J. H. Herman,Cartilage metabolism and anti-inflammatory drugs in osteoarthritis. Am. J. Med.81 (suppl. 5B), 36–43 (1986).
F. Lapicque, R. Jankowski, P. Netter, B. Bannwarth, C. Guillemin, M. C. Béné, C. Monot and M. Wayoff,Drug assay in ground tissues. Example of ketoprofen diffusion into the tonsillar tissue. J. Pharm. Sci.79, 791–795 (1990).
O. Heizmann, J. Körner and K. Zinapold,Determination of tenoxicam in human plasma by high-performance liquid chromatography. J. Chromatogr.374, 95–102 (1986).
H. S. Spahn, K. Thabe, E. Mutschler, K. Tillmann and I. Gikalov,Concentration of azapropazone in synovial tissues and fluid. Eur. J. Clin Pharmacol.32, 303–307 (1987).
M. Kurowski and H. Thabe,The transsynovial distribution of oxaprozin. Agents Actions27, 458–460 (1989).
W. J. Wallis and P. A. Simkin,Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics. Clin. Pharmacokinet.8, 496–522 (1983).
D. Bontoux, A. G. X. Phelip and J. B. Fourtillan,Pharmacokinetics of piroxicam in synovial fluid, synovial membrane, and cartilage. InThe rheumatological disease process: focus on piroxicam (Ed. R. G. Richardson) Royal Society of Medicine, International Congress and Symposium Series, No. 67 (1984).
A. Gaucher, P. Netter, G. Faure, J. P. Schoeller and A. Gérardin,Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid. Eur. J. Clin. Pharmacol.25, 107–112 (1983).
P. Franchimont, C. Bassleer and Y. Henrotin,Effects of hormones and drugs on cartilage repair. J. Rheumatol.16 (suppl. 18), 5–9 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bannwarth, B., Netter, P., Lapicque, F. et al. Tenoxicam concentrations in synovium and joint cartilage in humans. Agents and Actions 32, 295–298 (1991). https://doi.org/10.1007/BF01980889
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01980889